SANTA ANA, Calif. , Feb. 28, 2024 /PRNewswire/ -- Autonomous Medical Devices Incorporated (AMDI) has received a National Institutes of Health (NIH) RADx Tech award from the National Institute of Biomedical Imaging and Bioengineering ...
From an article recently published in the Journal of Allergy and Clinical Immunology: Global FREDERICK, Md. , Feb. 27, 2024 /PRNewswire-PRWeb/ -- Kenneth Dretchen, PhD, of Mesa Science Associates, in collaboration with researchers from ...
Founder and Expert Biologist, Dr. Cliff Han , Shares Findings in "American Journal of Translational Research" in Preparation for a National Market Rollout LOS ALAMOS, N.M. , Feb. 20, 2024 /PRNewswire/ -- In a completely novel approach ...
FAIRFAX, Va. , Feb. 13, 2024 /PRNewswire/ -- Allergy & Asthma Network, a nonprofit patient education and advocacy organization, and Blue Marble Health, an innovative digital health technology company, are pleased to announce they are ...
BERGEN, Norway , Feb. 7, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that Dr. Mirella ...
MANILA, Philippines , Jan. 29, 2024 /PRNewswire/ -- Consumer advocacy group Quit for Good asked the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) to consider the lives of more than a billion smokers when it ...
Acceptance of harm reduction, education and open dialogue are the keys to succeed MONTREAL , Jan. 22, 2024 /CNW/ - At the start of National Non-Smoking Week, Imperial Tobacco Canada (ITCAN) urges governments and public health ...
E-Cigarette use has fallen from 14% in 2022 to 10% in 2023, among high school students in US, while cigarette use remained at an all-time low, reveals CDC & FDA Survey NEW DELHI , Jan. 17, 2024 /PRNewswire/ -- A recent study ...
OTTAWA, ON , Dec. 14, 2023 /CNW/ - Respiratory illness season is well underway in Canada . While respiratory infections can occur year-round, it is common to see a significant increase in the fall and winter months. For some areas where ...
Chiesi Group and Haisco Pharmaceutical will collaborate closely to develop HSK31858, a novel reversible dipeptidyl peptidase 1 (DPP1) inhibitor for respiratory diseases. This agreement expands Chiesi's comprehensive R&D program in ...
The rising prevalence of chronic respiratory illnesses like Chronic Obstructive Pulmonary Disease (COPD) and asthma is projected to drive a 4% compound annual growth rate (CAGR) in India's critical care ventilator services market by 2033. ...
Although a persistent cough has traditionally been considered a key symptom of tuberculosis , it is imperative to explore new diagnostic approaches for the world's most lethal infection. A recent study revealed that a majority of patients do not ...
Australian researchers have made a noteworthy breakthrough in addressing severe asthma cases. Their findings indicate that beta common cytokines, a category of proinflammatory molecules, play a pivotal role in controlling inflammation and airway scarring, especially in instances of severe asthma that are resistant to steroid treatment. ...
Scientific literature emphasizes the pivotal role of CD4+ T cells in responding to lung infections. Yet, a Cell Reports article reveals that an imbalance in these defense cells across lung regions during infection can be detrimental in tuberculosis condition . ...
Asthma is more prevalent among individuals in the U.S. who have reported cannabis use in the last 30 days. The likelihood of asthma is notably higher in those who reported cannabis use for 20 to 30 days per month, stated Columbia University Mailman ...
Subscribe to our Free Newsletters!